Merck Handed First Loss in Fosamax Bellweather Trials

Sunday, 10 February 2013
News Roundup
The Merck Pharmacy in New York City 1897

A jury in New York City federal court has ruled that pharmaceutical giant Merck didn’t properly warn users about the risks associated with its osteoporosis drug Fosamax, according to a recent article from Reuters.

Read more...

Visit other PMG Sites:
PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.
Ok Decline